Company news
Hualan Biological Engineering Inc. Class A (SZSE:002007) news
Hualan Biological Engineering Inc. Class A news releases on 6ix. Latest, Apr 27, 2026: Hualan Biological Engineering: Revenue and profit fell sharply…
Press releases & updates
Hualan Biological Engineering: Revenue and profit fell sharply year-over-year amid regulatory and tax changes
April 26, 2026
Hualan Biological Engineering: 2025 revenue rose 4.93% to ¥4.60B, net profit fell 13.55% to ¥940M, dividend payout 97%
March 27, 2026
Hualan Biological Engineering: Q3 2025 saw a 14% revenue drop and 44.45% net profit decline year-over-year
October 30, 2025
Hualan Biological Engineering: Net profit rose 17.2% year-over-year on strong blood product sales and higher R&D investment
August 28, 2025
Hualan Biological Engineering: Revenue and net profit rose, but cash flow weakened amid higher investment outflows
April 28, 2025
Hualan Biological Engineering: Net profit fell 26.6% as vaccine sales dropped, but blood products revenue grew 10.9%
March 28, 2025
Hualan Biological Engineering: Revenue and profit fell in Q3 2024, with cash flow and working capital under pressure
October 29, 2024
Hualan Biological Engineering: Revenue up, profit down as vaccine sales drop and blood products drive growth
August 29, 2024